Literature DB >> 18792081

Extracting more information from behaviour checklists by using components of mean based scores.

John R Taffe1, Bruce J Tonge, Kylie M Gray, Stewart L Einfeld.   

Abstract

Sums of responses to behaviour checklist items are commonly used as outcome measures. We argue for the use of mean scores. For sets of responses registering absence and presence at different levels of intensity of behaviours we also show that mean scores may usefully be 'decomposed' into separate measures of the range and the intensity of problematic behaviours. These separate measures are the proportion of items positively endorsed and the 'intensity index' - the proportion of positive scores that are above one. We illustrate their use with primary outcome scores from the Developmental Behaviour Checklist (DBC) in the Australian Child to Adult Development Study. The low mean scores of young people with profound intellectual disability are shown to be a function of the narrow range of behaviours they display rather than of the level of intensity of these behaviours, which is relatively high. Change over time in mean scores is shown to be attributable to change in both the range and the intensity of behaviours as young people age in the study. We show how the technique of measuring these two separate strands contributing to mean scores may be applied to checklists with sets of responses longer than the zero, one, two of the DBC. Copyright (c) 2008 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2008        PMID: 18792081      PMCID: PMC6878409          DOI: 10.1002/mpr.260

Source DB:  PubMed          Journal:  Int J Methods Psychiatr Res        ISSN: 1049-8931            Impact factor:   4.035


  8 in total

1.  The development of a new measure for the assessment of psychopathology in adults with intellectual disability.

Authors:  C Mohr; B J Tonge; S L Einfeld
Journal:  J Intellect Disabil Res       Date:  2005-07

2.  Population prevalence of psychopathology in children and adolescents with intellectual disability: I. Rationale and methods.

Authors:  S L Einfeld; B J Tonge
Journal:  J Intellect Disabil Res       Date:  1996-04

3.  Psychopathology in young people with intellectual disability.

Authors:  Stewart L Einfeld; Andrea M Piccinin; Andrew Mackinnon; Scott M Hofer; John Taffe; Kylie M Gray; Daniel E Bontempo; Lesa R Hoffman; Trevor Parmenter; Bruce J Tonge
Journal:  JAMA       Date:  2006-10-25       Impact factor: 56.272

4.  The Developmental Behavior Checklist: the development and validation of an instrument to assess behavioral and emotional disturbance in children and adolescents with mental retardation.

Authors:  S L Einfeld; B J Tonge
Journal:  J Autism Dev Disord       Date:  1995-04

5.  Short form of the developmental behaviour checklist.

Authors:  John R Taffe; Kylie M Gray; Stewart L Einfeld; Marielle C Dekker; Hans M Koot; Eric Emerson; Terhi Koskentausta; Bruce J Tonge
Journal:  Am J Ment Retard       Date:  2007-01

6.  Factor analysis of the Nisonger Child Behavior Rating Form in children with autism spectrum disorders.

Authors:  Luc Lecavalier; Michael G Aman; David Hammer; Wendy Stoica; Gregory L Mathews
Journal:  J Autism Dev Disord       Date:  2004-12

7.  The aberrant behavior checklist: a behavior rating scale for the assessment of treatment effects.

Authors:  M G Aman; N N Singh; A W Stewart; C J Field
Journal:  Am J Ment Defic       Date:  1985-03

8.  Population prevalence of psychopathology in children and adolescents with intellectual disability: II. Epidemiological findings.

Authors:  S L Einfeld; B J Tonge
Journal:  J Intellect Disabil Res       Date:  1996-04
  8 in total
  9 in total

1.  Coping, daily hassles and behavior and emotional problems in adolescents with high-functioning autism/Asperger's Disorder.

Authors:  Angela S Khor; Glenn A Melvin; Sophie C Reid; Kylie M Gray
Journal:  J Autism Dev Disord       Date:  2014-03

2.  Adult outcomes in autism: community inclusion and living skills.

Authors:  Kylie M Gray; Caroline M Keating; John R Taffe; Avril V Brereton; Stewart L Einfeld; Tessa C Reardon; Bruce J Tonge
Journal:  J Autism Dev Disord       Date:  2014-12

3.  Autism Spectrum Disorder in the DSM-5: Diagnostic Sensitivity and Specificity in Early Childhood.

Authors:  Jessica A Christiansz; Kylie M Gray; John Taffe; Bruce J Tonge
Journal:  J Autism Dev Disord       Date:  2016-06

4.  Trajectories of internalizing and externalizing symptoms among adults with autism spectrum disorders.

Authors:  Ashley C Woodman; Marsha R Mailick; Jan S Greenberg
Journal:  Dev Psychopathol       Date:  2015-11-27

5.  Comparing Parental Well-Being and Its Determinants Across Three Different Genetic Disorders Causing Intellectual Disability.

Authors:  Yuka Mori; Jenny Downs; Kingsley Wong; Jane Heyworth; Helen Leonard
Journal:  J Autism Dev Disord       Date:  2018-05

6.  Patterns of depressive symptoms and social relating behaviors differ over time from other behavioral domains for young people with Down syndrome.

Authors:  Kitty-Rose Foley; Jenny Bourke; Stewart L Einfeld; Bruce J Tonge; Peter Jacoby; Helen Leonard
Journal:  Medicine (Baltimore)       Date:  2015-05       Impact factor: 1.889

7.  Day occupation is associated with psychopathology for adolescents and young adults with Down syndrome.

Authors:  Kitty-Rose Foley; Peter Jacoby; Stewart Einfeld; Sonya Girdler; Jenny Bourke; Vivienne Riches; Helen Leonard
Journal:  BMC Psychiatry       Date:  2014-10-03       Impact factor: 3.630

8.  Young People with Intellectual Disability Transitioning to Adulthood: Do Behaviour Trajectories Differ in Those with and without Down Syndrome?

Authors:  Kitty-Rose Foley; John Taffe; Jenny Bourke; Stewart L Einfeld; Bruce J Tonge; Julian Trollor; Helen Leonard
Journal:  PLoS One       Date:  2016-07-08       Impact factor: 3.240

9.  The Profiles and Correlates of Psychopathology in Adolescents and Adults with Williams, Fragile X and Prader-Willi Syndromes.

Authors:  R Royston; C Oliver; P Howlin; A Dosse; P Armitage; J Moss; J Waite
Journal:  J Autism Dev Disord       Date:  2020-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.